# Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/abrocitinib-versus-placebo-or-dupilumab-for-atopic-dermatitis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thomas Bieber,Eric L. Simpson,Jonathan I. Silverberg,Diamant Thaçi,C. Paul,Andrew Pink,Yoko Kataoka,Chia‐Yu Chu,Marco DiBonaventura,Ricardo Rojo,Jeremias Antinew,Ileana A. Ionita,Rodney Sinclair,Seth Forman,Jacek Zdybski,Pinaki Biswas,Bimal Malhotra,Fan Zhang,Hernán Valdez |
| Citations | 462 |
| DOI | 10.1056/nejmoa2019380 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa2019380?articleTools=true |
| OpenAlex ID | https://openalex.org/W3136297743 |
| PMID | 33761207 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Thomas Bieber](https://scholariq.org/researchers/thomas-bieber/)
- [Marco DiBonaventura](https://scholariq.org/researchers/marco-dibonaventura/)
- [Chia‐Yu Chu](https://scholariq.org/researchers/chia-yu-chu/)
- [Jonathan I. Silverberg](https://scholariq.org/researchers/jonathan-i-silverberg/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.